Trial
NCT04411472
(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
AM-Pharma
Collaborators
—
Condition
Acute Kidney Injury Due to Sepsis
Intervention
Recombinant human alkaline phosphatase
Why stopped
The Data Monitoring Committee (DMC) concluded that the pre-specified futility threshold was met and that there was no safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-03